Medipharm Labs Corp T.LABS

Question: Once LABS has 4 or 5 approved drugs, can they

[piduks]

SELL the rights to those drugs to larger pharmaceutical companies along with a small royalty structure?

[piduks]

jump into the Chevy, heading for big lights, want to know the rest?  Hey...BUY THE RIGHTS. 

[Solid1]

That's more or less how I imagine it too That Medipharm Labs gets the rights/licenses to produce these new drugs and pays a license fee. 

[QContinuum1]

LABS is a long way from any 'new drug'.  Closest they are is with Epidiolex and even that is looking ever more unlikely in the short term given the recent ruling in the US against one (or more) of the defendants in the patent case.  Drob could be a secret weapon here if the shortages are as bad as people claim and LABS can fill that void with cheaper better product.  Hoping

[mdjbrown]

QC1, it would be nice if Medipharm would expand on the following statement they made recently and in particular the IND's. "MediPharm has been referenced in FDA Investigational New Drug Applications, an Abbreviated New Drug Application and a Drug Master File." Also, it would be helpful to know as a shareholder if Medipharm is in fact involved in any of the 20 late stage trials in

[QContinuum1]

The MD&A is clear on which clinical trials LABS is associated with and none are 'late-stage' and the amount does not total 20. But I agree fully that they need to provide shareholders an update in the status, and more importantly, differences between the NDA, ANDA (if in fact they are different) and the 501.  Strachan did let out in one call that the ANDA was for Epiodolex, but